Roivant Sciences Ltd annual earnings per share (EPS) for fiscal 2026 was $-0.43, a decrease of 79.2% from $-0.24 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | — | $-0.43 | $-0.24 | $5.23 | $-1.42 | $-1.26 | $-1.18 | $1.75 | $-4.84 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | — | $0.37 | $-0.38 | $-0.17 | $-0.33 | $-0.29 | $0.23 | $-0.31 | $-0.31 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ROIV metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All ROIV financial statements → Interactive ROIV charts →
About TickerBase · Data methodology & sources · Privacy · Terms